NO163132C - Analogifremgangsm te for fremstilling av en terapeutisk aktiv 2-oksindol-1-karboksamid-forbindelse og mellomproduktfor fremstilling derav. - Google Patents
Analogifremgangsm te for fremstilling av en terapeutisk aktiv 2-oksindol-1-karboksamid-forbindelse og mellomproduktfor fremstilling derav.Info
- Publication number
- NO163132C NO163132C NO851774A NO851774A NO163132C NO 163132 C NO163132 C NO 163132C NO 851774 A NO851774 A NO 851774A NO 851774 A NO851774 A NO 851774A NO 163132 C NO163132 C NO 163132C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- oxindol
- intermediate products
- carboxamide compound
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60735684A | 1984-05-04 | 1984-05-04 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO851774L NO851774L (no) | 1985-11-05 |
| NO163132B NO163132B (no) | 1990-01-02 |
| NO163132C true NO163132C (no) | 1990-04-11 |
Family
ID=24431933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO851774A NO163132C (no) | 1984-05-04 | 1985-05-03 | Analogifremgangsm te for fremstilling av en terapeutisk aktiv 2-oksindol-1-karboksamid-forbindelse og mellomproduktfor fremstilling derav. |
Country Status (25)
| Country | Link |
|---|---|
| JP (1) | JPS60243068A (is) |
| KR (1) | KR870000497B1 (is) |
| AR (1) | AR241159A1 (is) |
| BG (2) | BG60208B2 (is) |
| CS (1) | CS252828B2 (is) |
| DD (1) | DD232916A5 (is) |
| EG (1) | EG17193A (is) |
| ES (2) | ES8609248A1 (is) |
| FI (1) | FI80016C (is) |
| HU (1) | HU196057B (is) |
| IE (1) | IE851103L (is) |
| IN (1) | IN161509B (is) |
| MA (1) | MA20424A1 (is) |
| MW (1) | MW1685A1 (is) |
| MX (1) | MX5839A (is) |
| NO (1) | NO163132C (is) |
| OA (1) | OA08098A (is) |
| PL (2) | PL145416B1 (is) |
| PT (1) | PT80375B (is) |
| RO (2) | RO94455B (is) |
| RU (1) | RU2017729C1 (is) |
| SU (1) | SU1468413A3 (is) |
| YU (1) | YU44998B (is) |
| ZA (1) | ZA853324B (is) |
| ZW (1) | ZW7885A1 (is) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
| IL95880A (en) * | 1989-10-13 | 1995-12-31 | Pfizer | Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis |
-
1985
- 1985-04-08 IN IN288/DEL/85A patent/IN161509B/en unknown
- 1985-04-30 YU YU730/85A patent/YU44998B/xx unknown
- 1985-04-30 PT PT80375A patent/PT80375B/pt unknown
- 1985-05-02 AR AR300259A patent/AR241159A1/es active
- 1985-05-02 EG EG275/85A patent/EG17193A/xx active
- 1985-05-02 IE IE851103A patent/IE851103L/xx unknown
- 1985-05-02 JP JP60095275A patent/JPS60243068A/ja active Granted
- 1985-05-02 DD DD85275898A patent/DD232916A5/de not_active IP Right Cessation
- 1985-05-03 KR KR1019850003013A patent/KR870000497B1/ko not_active IP Right Cessation
- 1985-05-03 BG BG070071A patent/BG60208B2/xx unknown
- 1985-05-03 MA MA20648A patent/MA20424A1/fr unknown
- 1985-05-03 ZW ZW78/85A patent/ZW7885A1/xx unknown
- 1985-05-03 PL PL1985253203A patent/PL145416B1/pl unknown
- 1985-05-03 NO NO851774A patent/NO163132C/no not_active IP Right Cessation
- 1985-05-03 MX MX583985A patent/MX5839A/es unknown
- 1985-05-03 MW MW16/85A patent/MW1685A1/xx unknown
- 1985-05-03 FI FI851756A patent/FI80016C/fi not_active IP Right Cessation
- 1985-05-03 ZA ZA853324A patent/ZA853324B/xx unknown
- 1985-05-03 OA OA58583A patent/OA08098A/xx unknown
- 1985-05-03 PL PL1985257892A patent/PL147508B1/pl unknown
- 1985-05-03 RO RO123678A patent/RO94455B/ro unknown
- 1985-05-03 RO RO118604A patent/RO91141B/ro unknown
- 1985-05-03 ES ES542813A patent/ES8609248A1/es not_active Expired
- 1985-05-04 CS CS853202A patent/CS252828B2/cs not_active IP Right Cessation
- 1985-05-04 RU SU853891002A patent/RU2017729C1/ru active
- 1985-05-31 HU HU851693A patent/HU196057B/hu unknown
-
1986
- 1986-01-27 ES ES551275A patent/ES8707182A1/es not_active Expired
- 1986-05-12 SU SU864027453A patent/SU1468413A3/ru active
-
1992
- 1992-07-08 BG BG096583A patent/BG60207B2/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO164025C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater. | |
| NO162113C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminforbindelser. | |
| NO162189C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner. | |
| NO161497C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater. | |
| NO165397C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
| NO157738C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazinoner og benzoksazolinoner. | |
| NO871028D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater. | |
| NO164541C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater. | |
| NO169963C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner | |
| NO883500D0 (no) | Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan. | |
| NO862534L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater og beslektede forbindelser. | |
| NO163775C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner. | |
| NO164295C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser. | |
| NO167664C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider. | |
| NO164899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser. | |
| NO873680L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser. | |
| NO894949D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzopyranylpyrrolinonderivater. | |
| NO163570C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner. | |
| NO891009L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocyklokeptenderivater. | |
| NO162188C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner. | |
| NO170012C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider | |
| NO163132C (no) | Analogifremgangsm te for fremstilling av en terapeutisk aktiv 2-oksindol-1-karboksamid-forbindelse og mellomproduktfor fremstilling derav. | |
| NO163617C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater. | |
| NO166322C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroapovincaminsyrederivater. | |
| NO160712C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-forbindelser. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |